[EN] INDOLYL-THIENO`3,4-B!PYRAZIN-3-ONE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS [FR] DERIVES D'INDOLYL-THIENO`3,4-B!PYRAZIN-3-ONE UTILISES POUR TRAITER LES MALADIES ET LES TROUBLES HYPER-PROLIFERATIFS ASSOCIES A L'ANGIOGENESE
[EN] INDOLYL PYRAZINONE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS<br/>[FR] DERIVES D'INDOLYLE PYRAZINONE UTILES POUR LE TRAITEMENT DES MALADIES ET DES TROUBLES HYPERPROLIFERANTS ASSOCIES A L'ANGIOGENESE
申请人:BAYER PHARMACEUTICALS CORP
公开号:WO2004043950A1
公开(公告)日:2004-05-27
This invention relates to a compound of Formula I (I)and its use in treating hyper-proliferative disorders and diseases associated with angiogenesis.
这项发明涉及一种式I(I)化合物及其在治疗与血管生成有关的高增殖性疾病和疾病中的应用。
Indolyl pyrazinone derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
申请人:Ladouceur H Gaetan
公开号:US20060004011A1
公开(公告)日:2006-01-05
This invention relates to a compound of Formula I (I) and its use in treating hyper-proliferative disorders and diseases associated with angiogenesis.
本发明涉及一种I式化合物及其在治疗与血管生成相关的过度增殖性疾病中的应用。
Indolyl-thienopyrazinone derivatives useful for treating hyperproliferative disorders and diseases associated with angiogenesis
申请人:Cook James
公开号:US20070105851A1
公开(公告)日:2007-05-10
This invention relates to a compound of Formula (I): (I) and its use in treating hyper-proliferative disorders and diseases associated with angiogenesis.
本发明涉及一种式(I)的化合物:(I),以及其在治疗与血管生成相关的高增殖性疾病和疾病中的应用。
[EN] INDOLYL-THIENO`3,4-B!PYRAZIN-3-ONE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS<br/>[FR] DERIVES D'INDOLYL-THIENO`3,4-B!PYRAZIN-3-ONE UTILISES POUR TRAITER LES MALADIES ET LES TROUBLES HYPER-PROLIFERATIFS ASSOCIES A L'ANGIOGENESE
申请人:BAYER PHARMACEUTICALS CORP
公开号:WO2005051957A1
公开(公告)日:2005-06-09
This invention relates to a compound of Formula (I): (I) and its use in treating hyper-proliferative disorders and diseases associated with angiogenesis.